ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $549,000 | +19.3% | 3,443 | -1.6% | 0.06% | +22.0% |
| Q2 2021 | $460,000 | +6.7% | 3,498 | +4.5% | 0.05% | -21.9% |
| Q1 2021 | $431,000 | +1.2% | 3,346 | +31.1% | 0.06% | -15.8% |
| Q4 2020 | $426,000 | +55.5% | 2,552 | +43.6% | 0.08% | +33.3% |
| Q3 2020 | $274,000 | +9.2% | 1,777 | -0.7% | 0.06% | +5.6% |
| Q2 2020 | $251,000 | +20.7% | 1,789 | +15.5% | 0.05% | -1.8% |
| Q1 2020 | $208,000 | – | 1,549 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |